Moderna, Inc.

We are mRNA. And mRNA is us.

Every day, we come together to create the blueprints needed to fight and eradicate diseases, and to help people live healthier lives. And the world has witnessed the powerful benefits of our platform technology.

With mRNA technology, we are completely reimagining how medicines are created and delivered. And in the process, we’re launching an entirely new industry, one fueled by deep care for our teams as well as for others.

Through the power of mRNA, we’re giving our people a platform to change medicine—and an opportunity to change the world.

Come with us as we pursue the uncharted reaches of possibility and make your mark on the future of medicine: modernatx.com/careers

200 Technology Square
Cambridge, MA

Tel: 617-714-6500

Visit website

Email Us

Stock Symbol: MRNA
Stock Exchange: USNASDAQ GS

Changing the future of medicine starts with our people. Across Moderna, our colleagues are working to make the impossible possible, and our goal is to support them every step of the way. Our workforce has grown significantly over the last few years as we have rapidly scaled to become a global commercial company. With more than 5,500 people around the world, we are focused on creating an environment that is rooted in a strong sense of belonging. Hear from our changemakers.

Every Role Matters, Enabling Transformative Mission

At Moderna, our changemakers are actively building a better future, one innovation at a time. We recently asked Keke if she could create a six-word story about what being a changemaker meant to her.

Read Keke’s Story

Take your moment with benefits

We know that you will give us your all and we want to make sure that we’re doing the same for you and the people closest to you. We’re on this incredible journey of pushing past the possible together, which is why we provide paramount support for both you and your family.

Learn More

NEWS

Drug Development

Coronavirus Update: Vaccines Rushing into Clinical Trials

As the coronavirus outbreak that causes COVID-19 escalates, biopharma companies and government agents are working quickly to develop and test a vaccine, although most estimates are it will take 12 to 18 months before it could get to market.

March 5, 2020

7 min read

Mark Terry

Genetown

Moderna’s Coronavirus Vaccine Ready for Clinical Trials

As the number of cases and deaths continues to increase in China and around the world, Moderna shipped its first batch of mRNA-1273, a vaccine against the virus, for a planned Phase I clinical trial in the U.S.

February 25, 2020

3 min read

Mark Terry

Credit: CDC Public Health Image Library (PHIL) #23

Policy

Mobilizing Drug Development Efforts Against the Novel Coronavirus

Now that global responses are fully mobilized, what is being done to identify and develop drugs and vaccines against this novel coronavirus?

February 14, 2020

15 min read

Chelsea Weidman Burke

BioCapital

Coronavirus Update: Now Dubbed COVID-19, with Death Toll Passing 1,100

The World Health Organization (WHO) gave the coronavirus that began in Wuhan, China, an official name, COVID-19.

February 12, 2020

4 min read

Mark Terry

Pharm Country

China Coronavirus Update: Continued Spread, Run on Antivirals and Facemasks, Baby Diagnosed

The most recent figure for the China coronavirus outbreak is 28,018 confirmed cases with 563 deaths in China. Chinese health authorities indicate 19 foreigners have been infected by the virus. There are reports that a Chinese newborn is the youngest person to become infected. The infant was diagnosed 30 hours after birth, apparently having gotten it from the mother.

February 6, 2020

4 min read

Mark Terry

Pharm Country

China Coronavirus Update: An Interview with Infectious Disease Specialist Sean Beckmann

The spreading of the coronavirus that began in Wuhan, China has researchers and health officials worldwide studying the emerging virus and preparing to treat it and develop vaccines. With such an enormous global focus, it seems that new information about the virus and the infection is being published each day.

January 31, 2020

6 min read

Mark Terry

Business

As Chinese Coronavirus Spreads, Biopharma and Governments Rush to Develop Vaccines

China’s National Health Commission stated today that the coronavirus has infected 5,974 individuals, resulting in 132 deaths and 103 people being cured.

January 29, 2020

5 min read

Mark Terry

Policy

China Coronavirus Update: What it is, How Dangerous it is, What is Being Done

The new coronavirus infection appears connected to a seafood market in Wuhan City in China, which has more a population of more than 11 million.

January 22, 2020

4 min read

Mark Terry

Policy

J.P. Morgan Day 4: Moderna, Berkeley Lights, Sanofi, Pfizer and More

As the J.P. Morgan Healthcare Conference winds down for 2020, one of the big topics was the general lack of big deals. Still, there were some general trends and for today, some news.

January 16, 2020

5 min read

Mark Terry

JOBS